Cartilage Transplant

In 1994 Lars Peterson published the first results on chondrocyte transplantation in patients with cartilage lesions. A new era has begun! The method called ACI (Autologus Chondrocytes Implantation) was complex and involved a biopsy, culture of the patient’s cells and reimplantation with periosteum coverage.

Since then, techniques have evolved from a method involving two surgeries to one called “one step.”

Dr. Prof. Gobbi devised a “one step” method called HA-BMAC in 2005.

Transplantation With Chondrocytes

Autologous transplantation techniques of chondrocytes of the first and second generation aim to regenerate articular cartilage, not just repair it. In this way, it is possible to restore the patient’s full ability to move the joint without pain and prevent further tissue degeneration.

Traditional ACI Technique

Autologous chondrocyte transplantation with ACI (Autologous Chondrocyte Implantation) technique involves the administration at the site of the injury of a fluid in which the patient’s chondrocytes cultured in the laboratory (better termed autologous chondrocytes) are suspended.

In order to keep the cells in the lesion, it is necessary to apply a film, called periosteum, which is taken from the surface of the tibia and sewn to the healthy cartilage, forming an airtight “pocket.” This surgical technique, however, is quite complex and cannot be done arthroscopically.

Second-generation ACI techniques

Second generation ACI techniques were developed with the aim of improving the ACI technique and involve the use of the patient’s chondrocytes multiplied in the laboratory on a three-dimensional scaffold, specifically designed to allow the growth of the cells and to simplify their application in the damaged area of ​​the cartilage.

This scaffold consists of a biocompatible and biodegradable biomaterial (scaffold).

These new techniques, thanks to the scaffold, do not require the use of the periosteum to keep the cells at the site of the lesion, making surgery easier.

Second-generation products were introduced into clinical practice in 2000 and are indicated for the treatment of cartilage injuries of traumatic origin or resulting from instability or abnormal loading of the knee or due to a particular condition called osteochondritis dissecans.

The biological and physical properties of the scaffold used as support for the growth of chondrocytes are very important because they affect the regenerative capabilities of the engineered cartilage.

The scaffold is based on hyaluronic acid, a natural component of cartilage, which is perfectly biocompatible and reabsorbed within 3 months after application. The scaffold promotes the growth of chondrocytes and is easily applied at the site of the cartilage defect.

It is important to note, however, that depending on the characteristics of the cartilage lesion and the patient’s expectations, each of the above techniques may prove effective. It will be up to the physician to judge which treatment is the most appropriate.

Autologous chondrocyte transplantation A.C.I. Generation I and II is an effective technique that results in regeneration of damaged cartilage by transplantation of autologous cartilage cells. It requires two surgical procedures: biopsy and implantation.

The Biopsy

The doctor through a very small incision made under local anesthesia introduces an arthroscope (a probe equipped with fiber optics) into the knee to precisely verify the extent of the injury. At this same time, the surgeon takes a biopsy.

The cells are then seeded onto the biomaterial where they continue the multiplication process and begin to form the new cartilage.

Implantation

Surgery is extremely simple and quick (about 20 to 30 minutes) and is usually minimally invasive for the patient, as it is performed by mini-arthrotomy or arthroscopy.

The mode of application is chosen by the surgeon based on the size and location of the lesion.

Mini-arthrotomy implantation:

The various stages of mini-arthrotomy surgery are as follows:

1. Preparation of the graft site: a mini-arthrotomy (a cut of about 6 cm) is performed by the surgeon to allow access to the defect and removal of damaged cartilage.
2. Preparation: the surgeon measures the size of the defect and cuts out an equal-sized portion of scaffold that fits and fills the defect area perfectly.
3. Placement: the biomaterial is gently laid over the cartilage defect.

Due to its bioadhesive properties, it remains at the graft site even during flexion and extension movements of the knee.

Arthroscopic implantation:

The various stages of arthroscopic surgery are as follows:

1. Using a cannula, the surgeon creates access to the cartilage lesion and measures its size.
2. The area to be treated is then prepared by removing the degenerated cartilage fragments. Preparation of the defect is done so as to create the predetermined circular area with well-defined margins suitable for receiving the graft.
3. A circular portion is cut out that will perfectly fit the prepared defect.
4. The biomaterial is placed in the area to be treated.

The entire procedure is repeated until the entire damaged area has been completely covered.

Then the knee is moved repeatedly to check that the graft remains well adhered to the defect site.

Transplantation with HA-BMAC One Step Technique

HAHyalrunoc Acid Scaffold (Hyalofast)

BMACBone Marrow Aspirate Concentrate

Bone marrow aspiration

A simpler and less expensive one-step procedure to repair and regenerate your cartilage.

Since 2005, Dr. Prof. Gobbi has been using the HA-BMAC one-step technique for his patients, which offers the possibility of treating cartilage lesions with a single procedure.

HA represents the hyaluronic acid scaffold (Hyalofast), while BMAC stands for Bone Marrow Aspirate Concentrate. The novelty of this technique is the use of mesenchymal cells to repair cartilage defects. It offers significant advantages over conventional cartilage transplantation methods: the procedure is simpler, can be performed in a single procedure, and is much less expensive.

Autologous Mesenchymal Cells

Mesenchymal cells, found in bone marrow, are multipotent cells with the ability to regenerate cartilage tissue.

The use of the Hyalofast scaffold is necessary to make these cells adhere and be protected in the area of ​​the cartilage lesion.

The HA-BMAC technique consists of aspiration of a small amount of marrow, filtration and concentration of the aspirate and subsequent implantation on the Hyalofast scaffold.

Through the use of a special activator (Plateltex act) we are able to make BMAC into a sticky, fairly malleable gel that adhered to Hyalofast can easily be applied where the cartilage lesion is.

Patients are then referred to a specific rehabilitation program, based on functional criteria and goals that are achieved at various stages of the program.

Dr. Prof. Gobbi has operated on hundreds of patients from around the world with the HA-BMAC technique, and the results have been published in the world’s most prestigious journals, such as the American Journal of Sports Medicine.

Testimonials from Our Patients

“At the end of the 2018 competitive season, I had great difficulty with physical activity due to a popliteal cyst caused by cartilage consumption. So I decided to rely on Dr. Gobbi, who decided to undergo an arthroscopic surgery in which he performed cartilage shaving and cartilage transplantation with HA-BMAC. Today, thanks to this surgery and infiltration with growth factors (PRP), I have resumed competitive activity. Thank you for everything.”

Gianluca Salvaneschi | Head of Strategic Business Development & IoT Southern & Central Europe, Orange Business Services; FIP (Italian Basketball Federation) Master Athlete, Milan, Italy